Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjarne Robberstad

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
BMC Public Health|May 29, 2024
Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020Lamprini Veneti, Bjarne Robberstad, Anneke Steens, et al.
Eclinicalmedicine|October 31, 2022
Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysisMelf-Jakob Kühl, Thandile Gondwe, Aggrey Dhabangi, et al.
JAMA|April 18, 2026
Long-Term Cognitive Ability and Academic Achievement After Childhood Severe MalariaPaul Bangirana, Kagan A Mellencamp, Jie Ren, et al.
BMJ Open|November 24, 2021
Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trialMartin N Mwangi, Glory Mzembe, Ernest Moya, et al.
Trials|November 8, 2018
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trialTitus K Kwambai, Aggrey Dhabangi, Richard Idro, et al.
The Lancet. Global Health|December 14, 2023
Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trialsKamija S Phiri, Carole Khairallah, Titus K Kwambai, et al.
Malaria Journal|February 19, 2025
Conceptualizing the implementation of post-discharge malaria chemoprevention in Malawi using a co-design approachMyness Kasanda Ndambo, Kristine Bærøe, Kamija Samuel Phiri, et al.
The New England Journal of Medicine|December 2, 2020
Malaria Chemoprevention in the Postdischarge Management of Severe AnemiaTitus K Kwambai, Aggrey Dhabangi, Richard Idro, et al.
Nature Communications|January 25, 2023
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in AfricaLucy C Okell, Titus K Kwambai, Aggrey Dhabangi, et al.
Trials|April 5, 2020
Reporting of health equity considerations in cluster and individually randomized trialsJennifer Petkovic, Janet Jull, Manosila Yoganathan, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
BMC Public Health|May 29, 2024
Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020Lamprini Veneti, Bjarne Robberstad, Anneke Steens, et al.
Eclinicalmedicine|October 31, 2022
Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysisMelf-Jakob Kühl, Thandile Gondwe, Aggrey Dhabangi, et al.
JAMA|April 18, 2026
Long-Term Cognitive Ability and Academic Achievement After Childhood Severe MalariaPaul Bangirana, Kagan A Mellencamp, Jie Ren, et al.
BMJ Open|November 24, 2021
Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trialMartin N Mwangi, Glory Mzembe, Ernest Moya, et al.
Trials|November 8, 2018
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trialTitus K Kwambai, Aggrey Dhabangi, Richard Idro, et al.
The Lancet. Global Health|December 14, 2023
Post-discharge malaria chemoprevention in children admitted with severe anaemia in malaria-endemic settings in Africa: a systematic review and individual patient data meta-analysis of randomised controlled trialsKamija S Phiri, Carole Khairallah, Titus K Kwambai, et al.
Malaria Journal|February 19, 2025
Conceptualizing the implementation of post-discharge malaria chemoprevention in Malawi using a co-design approachMyness Kasanda Ndambo, Kristine Bærøe, Kamija Samuel Phiri, et al.
The New England Journal of Medicine|December 2, 2020
Malaria Chemoprevention in the Postdischarge Management of Severe AnemiaTitus K Kwambai, Aggrey Dhabangi, Richard Idro, et al.
Nature Communications|January 25, 2023
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in AfricaLucy C Okell, Titus K Kwambai, Aggrey Dhabangi, et al.
Trials|April 5, 2020
Reporting of health equity considerations in cluster and individually randomized trialsJennifer Petkovic, Janet Jull, Manosila Yoganathan, et al.
Pageof 10